Beauty Health appoints Andrew Stanleick as President and CEO, effective Feb 7, 2022

SkinHealth Systems Inc.

Andrew Stanleick appointed President, CEO and board member effective Feb 7, 2022; Brent Saunders remains Executive Chairman.
Base salary $800,000; target annual bonus 100% of base; $800,000 signing cash bonus subject to clawback within 12 months.
Equity: 250,000 performance-based RSUs (stock price goals over 4 years); FY2022 annual grants of $4.5M time-based RSUs and $1.5M PSUs.
Stanleick brings 25+ years beauty/retail experience, most recently EVP Americas at Coty and CEO of Kylie Jenner Beauty.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Brenton L. Saunders

Interim Chief Executive Officer

SKIN · SkinHealth Systems Inc.

Effective: 2022-02-07
Successor: Andrew Stanleick
Filed: January 20, 2022, 6:59 PM ET

Upon Mr. Stanleick commencing employment as the Company’s Chief Executive Officer, Brenton L. Saunders, the current interim Chief Executive Officer of the Company and the Executive Chairman of the Board, will cease to serve as interim Chief Executive Officer.

Appointed

Andrew Stanleick

President and Chief Executive Officer

SKIN · SkinHealth Systems Inc.

Effective: 2022-02-07
Filed: January 20, 2022, 6:59 PM ET

On January 20, 2022, The Beauty Health Company (the “Company”) announced the appointment of Andrew Stanleick to serve as its President and Chief Executive Officer and as a member of the Company’s Board of Directors (the “Board”), effective as of February 7, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Brenton L. Saunders changed role as Interim Chief Executive Officer at SkinHealth Systems Inc..

Action: ceased to serve
Role: Interim Chief Executive Officer

Exact text from the filing

Upon Mr. Stanleick commencing employment as the Company’s Chief Executive Officer, Brenton L. Saunders, the current interim Chief Executive Officer of the Company and the Executive Chairman of the Board, will cease to serve as interim Chief Executive Officer.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Andrew Stanleick was appointed as President and Chief Executive Officer at SkinHealth Systems Inc..

Action: appointed
Role: President and Chief Executive Officer

Exact text from the filing

On January 20, 2022, The Beauty Health Company (the “Company”) announced the appointment of Andrew Stanleick to serve as its President and Chief Executive Officer and as a member of the Company’s Board of Directors (the “Board”), effective as of February 7, 2022.

View on SEC.gov

SkinHealth Systems Inc. filing history →

Source: SEC EDGAR

accession 0001818093-22-000017

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.